Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000930661-96-000249
Filing Date
1996-04-01
Accepted
1996-04-01 00:00:00
Documents
15
Period of Report
1995-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K 182976
2 BYLAWS OF CARRINGTON LABS EX-3.5 145237
3 CARRINGTON EMPLOYEE STOCK PUR. PLAN EX-10.29 26890
4 RESIGNATION AGREEMENT EX-10.68 39731
5 REVISED/RESTATED RESIGNATION AGREEMENT EX-10.69 26294
6 COMMON STOCK PURCHASE WARRANT EX-10.70 19107
7 CARRINGTON CONSULTING AGREEMENT EX-10.71 8961
8 NONQUALIFIED STOCK OPTION AGREEMENT EX-10.72 13596
9 NONQUALIFIED STOCK OPT. AGR. NONEMPL. DIR. EX-10.73 9781
10 SUPPLY AND DISTRIBUTION AGREEMENT EX-10.76 44857
11 TERMINATION AGREEMENT EX-10.77 14537
12 COMPUTATION OF NET INCOME PER SHARE EX-11.1 2051
13 SUBSIDIARIES OF CARRINGTON EX-21.1 834
14 ARTHUR ANDERSEN CONSENT EX-23.1 983
15 FINANCIAL DATA SCHEDULE EX-27 2957
  Complete submission text file 0000930661-96-000249.txt   541823
Mailing Address 2001 WALNUT HILL LANE IRVING TX 75038
Business Address 2001 WALNUT HILL LN IRVING TX 75038 2145181300
CARRINGTON LABORATORIES INC /TX/ (Filer) CIK: 0000718007 (see all company filings)

EIN.: 751435663 | State of Incorp.: TX | Fiscal Year End: 1130
Type: 10-K | Act: 34 | File No.: 000-11997 | Film No.: 96542572
SIC: 2834 Pharmaceutical Preparations